Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV

Journal of Immunoassay and Immunochemistry

Volumn 28, Issue 2, 2007, Pages 155-168

  Attallah, Abdelfattah M ^a   Mosa, Tamer E ^a   Omran, Mohamed M ^a   Abo Zeid, Mostafa M ^b   El Dosoky, Ibrahim ^b   Shaker, Yehia M ^c  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Biomarkers; Collagens; Fibrosis; HCV; Score

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNODETECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGEN TYPE III; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRILLAR COLLAGENS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 33947588557     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701212088     Document Type: Article

References (37)

1. World Health Organization. Hepatitis C. Weekly Epidemiol. Rec. 1997, 72 (10), 65-69.
2. Attallah, A.M.; Ismail, H.; Tabll, A.A.; Shiha, G.E.; El-Dosoky, I. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection. J. Immunoassay Immunochem. 2003, 24 (4), 395-407.
3. Attallah, A.M.; Abdel Malak, C.A.; Elghawalby, N.A.; Shehatta, A.S.; Abdel-Raouf, M.; Shiha, G.E. Identification of a specific marker for hepatitis C virus infection using capillary zone electrophoresis. Clin. Chim. Acta 2004, 346 (2), 171-179.
4. Boccato, S.; Pistis, R.; Noventa, F.; Guido, M.; Benvegnu, L.; Alberti, A. Fibrosis progression in initially mild chronic hepatitis C. J. Viral Hepat. 2006, 13 (5), 297-302.
5. Attallah, A.M.; Shiha, G.E.; Abdel Malak, C.A.; Hagras, H.E.; Abdel-Razik, W.S.; Ismail, H. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV-infected individuals with pegylated interferon α-2a. Hepatol. Res. 2004, 28 (2), 68-72.
6. Thuluvath, P.J.; Krok, K.L. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am. J. Gastroenterol. 2005, 100 (9), 1981-1983.
7. Park, J.H.; Park, C.K.; Kim, E.S.; Park, S.Y.; Jo, C.M.; Tak, W.Y.; Kweon, Y.O.; Kim, S.K.; Choi, Y.W. The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients. Taehan. Kan. Hakhoe. Chi. 2003, 9 (2), 79-88.
8. Murawaki, Y.; Koda, M.; Okamoto, K.; Mimura, K.; Kawasaki, H. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J. Gastroenterol. Hepatol. 2001, 16 (7), 777-781.
9. Wai, C.T.; Greenson, J.K.; Fontana, R.J.; Kalbfleisch, J.D.; Marrero, J.A.; Conjeevaram, H.S.; Lok, A.S. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38 (2), 518-526.
10. Callewaert, N.; Van Vlierberghe, H.; Van Hecke, A.; Laroy, W.; Delanghe, J.; Contreras, R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Natl. Med. 2004, 10 (4), 429-434.
11. Rosenberg, W.M.; Voelker, M.; Thiel, R.; Becka, M.; Burt, A.; Schuppan, D.; Hubscher, S.; Roskams, T.; Pinzani, M.; Arthur, M.J. European liver fibrosis group. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127 (6), 1704-1173.
12. Saitou, Y.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Kawakita, T.; Yamamoto, N.; Sugimoto, K.; Murata, K.; Nakano, T. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. J. Gastroenterol. 2005, 11 (4), 476-481.
13. Castera, L.; Vergniol, J.; Foucher, J.; Le Bail, B.; Chanteloup, E.; Haaser, M.; Darriet, M.; Couzigou, P.; De Ledinghen, V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128 (2), 343-350.
14. Attallah, A.M.; Shiha, G.E.; Omran, M.M.; Zalata, K.R. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol. Res. 2006, 34 (3), 163-169.
15. Attallah, A.M.; Toson, el-S.A.; El-Waseef, A.M.; Abo-Seif, M.A.; Omran, M.M.; Shiha, G.E. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from noncirrhotic liver diseased patients in chronic HCV infection. Clin. Chim. Acta 2006, 369 (1), 66-72.
16. Plebani, M.; Burlina, A. Biochemical markers of hepatic fibrosis. Clin. Biochem. 1991, 24 (3), 219-239.
17. Giannini, E.; Caglieris, S.; Ceppa, P.; Risso, D.; Lantieri, P.B.; Testa, R. Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C. Eur. J. Gastroenterol. Hepatol. 2001, 13 (2), 137-141.
18. Poynard, T.; Bedossa, P.; Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349 (9055), 825-832.
19. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76 (9), 4350-4354.
20. Xie, S.B.; Yao, J.L.; Zheng, S.S.; Yao, C.L.; Zheng, R.Q. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Hepatobil. Pancreat. Dis. Intl. 2002, 1 (2), 202-206.
21. Sakugawa, H.; Nakayoshi, T.; Kobashigawa, K.; Yamashiro, T.; Maeshiro, T.; Miyagi, S.; Shiroma, J.; Toyama, A.; Nakayoshi, T.; Kinjo, F.; Saito, A. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. J. Gastroenterol. 2005, 11 (2), 255-259.
22. Iushchuk, N.D.; Znoiko, O.O.; Safiullina, N.K.; Dudina, K.R.; Kelli, E.I.; Klimova, E.A.; Kashirin, V.I.; Braginskii, D.M.; Kushlinskii, N.E.; Liubimova, N.V.; Vasilev, A.I.; Penkina, T.V.; Danilin, A.G. Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis. Ter. Arkh. 2005, 77 (4), 50-55.
23. Lee, H.S.; Shun, C.T.; Chiou, L.L.; Chen, C.H.; Huang, G.T.; Sheu, J.C. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J. Gastroenterol. Hepatol. 2005, 20 (7), 1109-1114.
24. Myers, R.P.; Benhamou, Y.; Imbert-Bismut, F.; Thibault, V.; Bochet, M.; Charlotte, F.; Ratziu, V.; Bricaire, F.; Katlama, C.; Poynard, T. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003, 17 (5), 721-725.
25. Liang, X.H.; Zheng, H. Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis. Hunan Yi. Ke. Da. Xue. Xue. Bao. 2002, 27 (1), 67-68.
26. Xu, H.G.; Fang, J.P.; Huang, S.L.; Li, H.G.; Zhong, F.Y.; Guo, H.X.; Su, H. Diagnostic values of serum levels of HA, PC, III, C IV and LN to the liver fibrosis in children with beta-thalassemia major. Zhonghua Er. Ke. Za. Zhi. 2003, 41 (8), 603-606.
27. Ding, X.J.; Li, S.B.; Li, S.Z.; Liu, H.S.; Liu, B.; Xu, F.M.; Gu, R.W. A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases. Zhonghua. Gan. Zang. Bing. Za. Zhi. 2005, 13 (12), 911-914.
28. Santos, V.N.; Leite-Mor, M.M.; Kondo, M.; Martins, J.R.; Nader, H.; Lanzoni, V.P.; Parise, E.R. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz. J. Med. Biol. Res. 2005, 38 (5), 747-753.
29. Mayne, R.; Zettergren, J.G.; Mayne, P.M.; Bedwell, N.W. Isolation and partial characterization of basement membrane-like collagens from bovine thoracic aorta. Artery 1980, 7 (4), 262-280.
30. Mayne, R. Preparation and applications of monoclonal antibodies to different collagen types. Clin. Biochem. 1988, 21 (2), 11-15.
31. Kumagai, J.; Sarkar, K.; Uhthoff, H.K.; Okawara, Y.; Ooshima, A. Immunohistochemical distribution of type I, II and III collagens in the rabbit supraspinatus tendon insertion. J. Anat. 1994, 185 (2), 279-284.
32. Rojkind, M.; Giambrone, M.A.; Biempica, L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979, 76 (4), 710-719.
33. Murata, K.; Kudo, M.; Onuma, F.; Motoyama, T. Changes of collagen types at various stages of human liver cirrhosis. Hepatogastroenterology 1984, 31 (4), 158-161.
34. Lehmann, H.J.; Mouritzen, U.; Christgau, S.; Cloos, P.A.; Christiansen, C. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann. Rheum. Dis. 2002, 61 (6), 530-533.
35. Cai, W.M.; Zhang, B.B.; Weng, H.L.; Hu, Z.R.; Lv, J.; Zheng, M.; Liu, R.H. The diagnostic value of eight serum indices for liver fibrosis. Zhonghua. Gan. Zang. Bing. Za. Zhi. 2004, 12 (4), 219-222.
36. Walsh, K.M.; Fletcher, A.; MacSween, R.N.; Morris, A.J. Basement membrane peptides as markers of liver disease in chronic hepatitis C. J. Hepatol. 2000, 32 (2), 25-30.
37. Patel, K.; Gordon, S.C.; Jacobson, I.; Hezode, C.; Oh, E.; Smith, K.M.; Pawlotsky, J.M.; McHutchison, J.G. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis patients. J. Hepatol. 2004, 41, 935-942.